In order for a biomarker to be useful, it needs to be available and standardized across MRI platforms. Therefore, this aim will implement and standardize the above techniques across major MRI vendors and will test and ensure compatibility of the pulse sequences and data acquisitions. We will develop vendor-agnostic sequences using state-of-the-art platforms such as PulSeq and GammaStar. Furthermore, to ensure compatibility of data analysis, we will develop fully automated (i.e., rater-independent) processing pipelines, implement real-time parametric map generation on the MRI scanner, which is incorporated into the PACS database, and make our tools available to other researchers through container software and online deployments on our MRICloud. This effort will be conducted in close collaboration with TRD4.